Lilly Plans $72M Upgrade of Insulin Production Facility

Eli Lilly said today it will spend $72 million to help deliver on its promised expansion of insulin manufacturing in the U.S.—more than a month after the company unveiled a restructuring plan that will eliminate 8% of its workforce, approximately 3500 jobs.Lilly said it will replace an existing insulin vial-filling line and upgrading the technology at one of its Indianapolis insulin production facilities.“Our company is poised for continued growth, and diabetes represents one of our